Okay, let's tackle this question about the radiation emitted by Ir-192. First, I need to recall what Ir-192 is. I remember that Ir-192 is a radioisotope used in brachytherapy, which is a type of radiation therapy where the radiation source is placed inside or next to the area requiring treatment. The question is asking what type of radiation it emits.

The options aren't provided, but from the context, the correct answer is likely gamma rays. I think Ir-192 emits beta particles and gamma rays. Beta particles are high-energy electrons, and gamma rays are high-energy photons. In brachytherapy, gamma emitters like Ir-192 are used because gamma rays can penetrate tissue more effectively than beta particles. However, sometimes beta emitters are used for superficial treatments.

Wait, but wait—Ir-192 is known for emitting gamma rays. Let me double-check. Iridium-192 is a gamma emitter with a half-life of about 74 days. It's commonly used in high-dose-rate brachytherapy. So the radiation it emits is gamma radiation.

The other options might include alpha particles, beta particles, or maybe X-rays. Alpha particles don't penetrate much and are used in different contexts. Beta particles can be used in brachytherapy too, but Ir-192 is a gamma emitter. So the correct answer should be gamma rays.

Now, the incorrect options: If an option says alpha, beta, or X-rays, they need to be explained. Alpha particles have low penetration, so they're not used in brachytherapy for deep-seated tumors. Beta particles, like those from Sr-90, are used for superficial treatments. X-rays are electromagnetic but usually not emitted by Ir-192; it's a gamma emitter. So any option that's not gamma is wrong.

Clinical pearl: Remember that Ir-192 is a gamma emitter used in HDR brachytherapy. Different isotopes are used for different purposes—like Cs-137 for gamma, and I-125 for low-dose-rate with gamma as well. Beta emitters like P-32 are for superficial issues. So the key is the type of radiation and its medical application.

**Core Concept**
Iridium-192 (Ir-192) is a radioisotope used in high-dose-rate brachytherapy. It decays via **beta decay**, emitting **gamma radiation** as a secondary emission. Gamma rays are high-energy photons with greater tissue penetration than beta particles, making Ir-192 suitable for targeted cancer therapy.

**Why the Correct Answer is Right**
Ir-192 undergoes **beta decay** (emitting a beta particle) and subsequently releases **gamma photons** to stabilize its nucleus. The gamma rays (energy ~300–400 keV) are the primary therapeutic radiation in brachytherapy, delivering localized high-dose irradiation to tumors while minimizing damage to surrounding tissues. Its half-life of ~74 days allows controlled, time-limited treatment protocols.

**Why Each Wrong Option is Incorrect**
**Option A:** *Alpha particles* (helium nuclei) are not emitted by Ir-192. Alpha emitters (e.g

✓ Correct Answer: D. 0.47 Mev